← Back to Zydus Lifesciences Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

ZYDUSLIFEPharmaceuticals

Zydus Lifesciences Ltd — Financial Ratios & Key Metrics

₹871.20

+0.00%

P/E Ratio18.74xIndustry: 31.77x

ROE21.21%Return on equity

ROCE24.31%Return on capital

Debt/Equity0.38Low debt

💎

Valuation & Profitability

P/E Ratio

18.74x

Industry Average P/E

31.77x

Dividend Yield

1.17%

Market Cap

₹94.25K (Cr)

Sales Growth 5Y

10.27%

Profit Growth 5Y

25.92%

EPS Growth 5Y

26.36%

OPM 5Y Avg

25.73%

📉

Price Returns

1 Month

-3.90%

3 Months

-5.99%

6 Months

+0.53%

1 Year

-3.05%

52W Low

₹795

Current

₹871

52W High

₹1059

29% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹899

▼ Price below SMA 50 — Bearish

SMA 200

₹952

▼ Long-term downtrend

Volume Signal

62% of avg

Below average volume — low conviction

Technical indicators are for educational purposes only. Not investment advice.

More on Zydus Lifesciences Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.